new weight loss drug retatrutide (“reta”) is an experimental weight-loss currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide 2026: 28.7% Weight Loss

That being said, Dr

Similar content being viewed by others Introduction The incidence of certain allergic, autoimmune and metabolic diseases has been increasing in recent decades and has reached almost epidemic dimensions

Acknowledgements The authors would like to thank Henrik Kim Nielsen, Jens Heisterberg, and Karen Hauda (Novo Nordisk A/S, Denmark), and Gina MacNeil (Novo Nordisk Inc, United States) for review of, and input to, the manuscript, as well as Tina stergaard, Sisse Lakner Schmidt, and Michala Cronberg (Novo Nordisk A/S, Denmark) for help with physical stability analyses

While generally safe, those with specific health concerns or those who are pregnant or breastfeeding should consult a healthcare provider before using Epithalon

412 (2010): 1834, 10.1016/j.brainres.2010.03.059